To: Walter who wrote (28045 ) 9/14/1998 9:07:00 PM From: alan holman Read Replies (1) | Respond to of 28369
Well, I really do not believe it, BUT, it is in print. Lalit at the BXO SI site had it posted............................................. BRO-X TO MERGE WITH MACDONALD OIL 980914 - MACDONALD OIL EXPLORATION LTD.(MACO) - TORONTO, ONTARIO MacDonald Oil Exploration Ltd. (CDN: MACO) and Bro-X Minerals Ltd. have signed a letter of intent to seek all requisite approvals to merge. Under the terms of the letter of intent, MacDonald Oil shareholders would receive one share and one warrant of the merged company ("Amalco") for each MacDonald Oil share and Bro-X shareholders would receive two shares and one warrant of Amalco for every four shares held. The warrants would all be exercisable at $0.25 each at any time within twelve months of their issue. A Bro- X preferred share issue for $2 million, convertible into common shares at $1.00 each would become convertible at $0.25 per common share of Amalco. Bro-X has 22 million common shares issued and outstanding; MacDonald Oil has 18 million shares outstanding. 22% of Bro-X common shares and all its preferred shares are held by Bresea Resources Ltd. MacDonald Oil now holds a 30% interest in Block 22, the single largest onshore hydrocarbon exploration concession in Cuba, comprising 9,900 square kilometres. Earlier this summer MacDonald Oil announced its agreement to farm-out a 70% operating interest in Block 22, to Genoil Inc., a subsidiary of Beau Canada Exploration Ltd. An initial seismic program identified at least four potential drilling prospects which will be detailed with a further seismic program that commenced today. A first exploration well is scheduled for the second quarter of 1999. The operatorship of Beau Canada's Genoil Inc. has brought significant experience and economies to the companys' exploration programs in Cuba. ----- Frank C. Smeenk Thomas P. Devlin MacDonald Oil Exploration Ltd. Bro-X Minerals Ltd. Tel: (416) 865-1625 Tel: (403) 543-7080 Fax: (416) 865-9386 Fax: (403) 543-7060 No regulatory authority has approved nor disapproved the content of this news release.